1.84
Nrx Pharmaceuticals Inc (NRXP) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
0.242
|
- | - | - | - |
| Cost Of Revenue |
0.097
|
- | - | - | - |
| Gross Profit |
0.145
|
- | - | - | - |
|
|
11.77%
4.169
|
3.73 | 3.847 | 7.05 | 5.998 |
| Benefits Costs and Expenses |
4.266
|
- | - | - | - |
| Costs And Expenses |
4.266
|
- | - | - | - |
| Depreciation and Amortization |
0.026
|
- | - | - | - |
| Operating Income/Loss |
7.88%
-4.024
|
-3.73 | -3.847 | -7.05 | -5.998 |
| Nonoperating Income/Loss |
86.53%
-1.866
|
-13.85 | -1.664 | -0.847 | -0.53 |
| Income/Loss From Continuing Operations Before Tax |
77.11%
-4.024
|
-17.58 | -5.512 | -7.897 | -6.528 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
66.50%
-5.89
|
-17.58 | -5.512 | -7.897 | -6.528 |
|
|
66.50%
-5.89
|
-17.58 | -5.512 | -7.897 | -6.528 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
23.96%
22.23
|
17.93 | -0.7579 | 10.52 | 8.8523 |
| Basic Earnings Per Share |
72.45%
-0.27
|
-0.98 | -0.36 | -0.75 | -0.74 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):